Grieb, P.; Świątkiewicz, M.; Kamińska, A.; Jünemann, A.; Rejdak, R.; Rejdak, K.
Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis. Pharmaceuticals 2021, 14, 326.
https://doi.org/10.3390/ph14040326
AMA Style
Grieb P, Świątkiewicz M, Kamińska A, Jünemann A, Rejdak R, Rejdak K.
Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis. Pharmaceuticals. 2021; 14(4):326.
https://doi.org/10.3390/ph14040326
Chicago/Turabian Style
Grieb, Paweł, Maciej Świątkiewicz, Agnieszka Kamińska, Anselm Jünemann, Robert Rejdak, and Konrad Rejdak.
2021. "Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis" Pharmaceuticals 14, no. 4: 326.
https://doi.org/10.3390/ph14040326
APA Style
Grieb, P., Świątkiewicz, M., Kamińska, A., Jünemann, A., Rejdak, R., & Rejdak, K.
(2021). Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis. Pharmaceuticals, 14(4), 326.
https://doi.org/10.3390/ph14040326